PMC6456055

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models